Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure

被引：0
|
作者：
Luis Sargento
Andre Vicente Simões
Susana Longo
Nuno Lousada
Roberto Palma dos Reis
机构：
[1] Lisbon North Hospital Centre,Heart Failure Unit, Cardiology Department, Pulido Valente Hospital
[2] Lisbon North Hospital Centre,Department of Internal Medicine, Pulido Valente Hospital
来源：
Drugs & Aging | 2016年 / 33卷
关键词：
Heart Failure; Dose Level; Target Dose; Heart Failure Therapy; Heart Failure With Reduce Ejection Fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：675 / 683
页数：8
相关论文
共 50 条
  • [1] Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure
    Sargento, Luis
    Simoes, Andre Vicente
    Longo, Susana
    Lousada, Nuno
    dos Reis, Roberto Palma
    DRUGS & AGING, 2016, 33 (09) : 675 - 683
  • [2] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [3] Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis
    Khan, Muhammad Shahzeb
    Fonarow, Gregg C.
    Ahmed, Ali
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Khan, Hassan
    Marti, Catherine
    Gheorghiade, Mihai
    Butler, Javed
    CIRCULATION-HEART FAILURE, 2017, 10 (08)
  • [4] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [5] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
  • [6] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
    Chitnis, A. S.
    Johnson, M. L.
    Aparasu, R. R.
    Chen, H.
    Kunik, M. E.
    Schulz, P. E.
    VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [7] Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
    Chitnis, Abhishek S.
    Aparasu, Rajender R.
    Chen, Hua
    Kunik, Mark E.
    Schulz, Paul E.
    Johnson, Michael L.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 395 - 404
  • [8] Angiotensin-converting enzyme inhibitors and cytokines in heart failure: Dose and effect?
    Young, JB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) : 2068 - 2071
  • [9] Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure - Reply
    Johnson, D
    Cujec, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) : 1333 - 1334
  • [10] Short-term results in patients with acute heart failure under treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Haro Bosch, A.
    Cabello Zamora, I
    Fuentes Gonzalez, L.
    Lopez Delmas, N.
    Jacob Rodriguez, J.
    Malchair, P.
    EMERGENCIAS, 2023, 35 (03): : 235 - 236
12345